Quality by Design for Generic Drugs

To facilitate communication, the term CQA is reserved for attributes of the drug product. The term CMA is used for attributes of drug substance, excipient, and in-process materials. Generic-drug manufacturers should define the QTPP and CQAs before starting development work and share this information with FDA as a part of pharmaceutical development. ................
................